NeopharmCO.

네오팜KRX: 092730· Fiscal year 2025· neopharm.co.kr ↗

Average salary
$47.8K
₩63.7M
▲ 14.5% vs 2024
Employees
192
▲ 12.3% vs 2024
Average tenure
4.9 yrs

Estimated take-home of this pay:$3.3K / monthCalculate →

Workplace

Women's pay (men = 100)66
Women among staff52.6%
Contract staff0%

Recent official filings

Quick read

  • Average pay is 4% above the median of the companies we track.
  • Average pay rose 14.5% from 2024.
  • Headcount grew by 21 (12.3%) from 2024.
  • Ranks #176 of 367 Chemicals & Materials companies in this country by pay.
  • Revenue grew 11.1% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 21.8% in 2025.

Last 3 years

Revenue
$72.9M2023$89.3M2024$99.2M2025
Operating income
$19.0M2023$18.5M2024$21.6M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$515.5K
Net profit per employee
$108.5K
Operating margin
21.8%
Net margin
21.0%
ROE
14.2%
Debt-to-equity
11.5%
Equity ratio
89.7%
Payout ratio
42.2%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.